Perrigo Company plc Share-based Payment Arrangement, Decrease for Tax Withholding Obligation
Perrigo Company plc (PRGO) reported Share-based Payment Arrangement, Decrease for Tax Withholding Obligation of $4.20 million for the 3-month period ending 2026-06-27, per its 10-Q filed 2026-08-05.
Financial Statements › Notes › Equity
us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation · last filed 2026-08-05
- Perrigo Company plc share-based payment arrangement, decrease for tax withholding obligation for the quarter ending 2026-06-27 was $4.20M, a 26.32% decline year-over-year.
- Perrigo Company plc share-based payment arrangement, decrease for tax withholding obligation for the quarter ending 2026-03-28 was $2.80M, a 76.67% decline year-over-year.
- Perrigo Company plc share-based payment arrangement, decrease for tax withholding obligation for the quarter ending 2025-09-27 was $1.10M, a 83.33% increase year-over-year.
- Perrigo Company plc share-based payment arrangement, decrease for tax withholding obligation for the quarter ending 2025-06-28 was $5.70M, a 200.00% increase year-over-year.
- Perrigo Company plc share-based payment arrangement, decrease for tax withholding obligation for fiscal 2025 was $19.10M, a 23.23% increase from fiscal 2024.
- Perrigo Company plc share-based payment arrangement, decrease for tax withholding obligation for fiscal 2024 was $15.50M, a 15.30% decline from fiscal 2023.
- Perrigo Company plc share-based payment arrangement, decrease for tax withholding obligation for fiscal 2023 was $18.30M, a 3.68% decline from fiscal 2022.
- Perrigo Company plc share-based payment arrangement, decrease for tax withholding obligation for fiscal 2022 was $19.00M, a 43.94% increase from fiscal 2021.
| Period end | Share-based Payment Arrangement, Decrease for Tax Withholding Obligation 3 month | Share-based Payment Arrangement, Decrease for Tax Withholding Obligation 6 month | Share-based Payment Arrangement, Decrease for Tax Withholding Obligation 9 month | Share-based Payment Arrangement, Decrease for Tax Withholding Obligation 12 month |
|---|---|---|---|---|
| 2026-06-27 | $4.20M 10-Q · filed 2026-08-05 | $7.00M derived: sum of 2 quarters · filed 2026-08-05 | ||
| 2026-03-28 | $2.80M 10-Q · filed 2026-08-05 | |||
| 2025-12-31 | $19.10M 10-K · filed 2026-02-26 | |||
| 2025-09-27 | $1.10M 10-Q · filed 2025-11-05 | $6.80M derived: sum of 2 quarters · filed 2026-08-05 | $18.80M derived: sum of 3 quarters · filed 2026-08-05 | |
| 2025-06-28 | $5.70M 10-Q · filed 2026-08-05 | $17.70M derived: sum of 2 quarters · filed 2026-08-05 | ||
| 2025-03-29 | $12.00M 10-Q · filed 2026-08-05 | |||
| 2024-12-31 | $15.50M 10-K · filed 2026-02-26 | |||
| 2024-09-28 | $600.00K 10-Q · filed 2025-11-05 | $2.50M derived: sum of 2 quarters · filed 2025-11-05 | $15.00M derived: sum of 3 quarters · filed 2025-11-05 | |
| 2024-06-29 | $1.90M 10-Q · filed 2025-11-05 | $14.40M derived: sum of 2 quarters · filed 2025-11-05 | ||
| 2024-03-30 | $12.50M 10-Q · filed 2025-11-05 | |||
| 2023-12-31 | $18.30M 10-K · filed 2026-02-26 | |||
| 2023-09-30 | $2.50M 10-Q · filed 2024-11-06 | $4.00M derived: sum of 2 quarters · filed 2024-11-06 | $18.60M derived: sum of 3 quarters · filed 2024-11-06 | |
| 2023-07-01 | $1.50M 10-Q · filed 2024-11-06 | $16.10M derived: sum of 2 quarters · filed 2024-11-06 | ||
| 2023-04-01 | $14.60M 10-Q · filed 2024-11-06 | |||
| 2022-12-31 | $19.00M 10-K · filed 2025-02-28 | |||
| 2022-10-01 | $1.20M 10-Q · filed 2023-11-07 | $2.60M derived: sum of 2 quarters · filed 2023-11-07 | $19.00M derived: sum of 3 quarters · filed 2023-11-07 | |
| 2022-07-02 | $1.40M 10-Q · filed 2023-11-07 | $17.80M derived: sum of 2 quarters · filed 2023-11-07 | ||
| 2022-04-02 | $16.40M 10-Q · filed 2023-11-07 | |||
| 2021-12-31 | $13.20M 10-K · filed 2024-02-27 | |||
| 2021-10-02 | $2.90M 10-Q · filed 2022-11-08 | $4.10M derived: sum of 2 quarters · filed 2022-11-08 | $13.40M derived: sum of 3 quarters · filed 2022-11-08 | |
| 2021-07-03 | $1.20M 10-Q · filed 2022-11-08 | $10.50M derived: sum of 2 quarters · filed 2022-11-08 | ||
| 2021-04-03 | $9.30M 10-Q · filed 2022-11-08 | |||
| 2020-12-31 | $10.70M 10-K · filed 2023-02-28 | |||
| 2020-09-26 | $500.00K 10-Q · filed 2021-11-12 | $4.40M derived: sum of 2 quarters · filed 2021-11-12 | $10.00M derived: sum of 3 quarters · filed 2021-11-12 | |
| 2020-06-27 | $3.90M 10-Q · filed 2021-11-12 | $9.50M derived: sum of 2 quarters · filed 2021-11-12 | ||
| 2020-03-28 | $5.60M 10-Q · filed 2021-11-12 | |||
| 2019-12-31 | $5.60M 10-K · filed 2022-03-01 | |||
| 2019-09-28 | $1.10M 10-Q · filed 2020-11-05 | $1.90M derived: sum of 2 quarters · filed 2020-11-05 | $4.30M derived: sum of 3 quarters · filed 2020-11-05 | |
| 2019-06-29 | $800.00K 10-Q · filed 2020-11-05 | $3.20M derived: sum of 2 quarters · filed 2020-11-05 | ||
| 2019-03-30 | $2.40M 10-Q · filed 2020-11-05 | |||
| 2018-12-31 | $5.30M 10-K · filed 2021-03-01 | |||
| 2018-09-29 | $1.90M 10-Q · filed 2019-11-06 | $3.80M derived: sum of 2 quarters · filed 2019-11-06 | $5.30M derived: sum of 3 quarters · filed 2019-11-06 | |
| 2018-06-30 | $1.90M 10-Q · filed 2019-11-06 | $3.40M derived: sum of 2 quarters · filed 2019-11-06 | ||
| 2018-03-31 | $1.50M 10-Q · filed 2019-11-06 | |||
| 2017-12-31 | $4.00M 10-K · filed 2020-02-27 | |||
| 2016-12-31 | $6.30M 10-K · filed 2019-02-27 | |||
| 2015-12-31 | $10.30M 10-K · filed 2018-03-01 | |||
| 2015-06-27 | $7.60M 10-K · filed 2018-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |